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Abstract
Background: Diabetes is one of the most important chronic diseases and affects 9% of the world’s population. To
support these people in the day-to-day management of their treatments, pharmacies can offer professional
pharmacy services. These are defined as one or more actions organized or provided in a pharmacy to optimize the
process of care, with the goal of improving health outcomes and the value of healthcare. Such services have to be
tailored to the needs and interests of patients. This study aimed to evaluate interest in and use of pharmacy
services among people with diabetes in the canton of Vaud, Switzerland.
Methods: This cross-sectional study analysed self-reported data from 790 people with diabetes included in the CoDiab-VD
cohort. Questions focused on sociodemographic and economic characteristics, diabetes and its management, and interest in
and use of pharmacy services related to (1) medication intake and adherence and (2) diabetes and general health.
Descriptive analyses were first conducted. Logistic regression analyses were then performed for pharmacy services that were
of interest to ≥50% of respondents.
Results: The mean age of participants was 66 years, and the sample included more males (59%) than females.
The pharmacy services that interested the most respondents were individual interview, pill boxes or weekly
pill boxes, treatment plans, checks of all medications, first medical opinions from pharmacists and counselling
on devices. Factors significantly associated with interest in pharmacy services were being older, having a
lower self-efficacy score, taking more than three medications and having a positive opinion about
pharmacists.
Conclusions: This study provides key information on interest in and use of pharmacy services among
patients with diabetes in Switzerland; it should help pharmacists individualize their services for patients.
Keywords: Diabetes, Patient support, Pharmacy services, Primary care, Switzerland
© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: nourabawab@hotmail.com
ˆOlivier Bugnon is deceased.
†Jérôme Berger and Isabelle Peytremann-Bridevaux share last authorship.
1Community Pharmacy, Center for Primary Care and Public Health (Unisanté),
University of Lausanne, Rue du Bugnon 44, 1011 Lausanne, Switzerland
2School of Pharmaceutical Sciences, University of Geneva, Rue Michel-Servet
1, 1211 Geneva 4, Switzerland
Full list of author information is available at the end of the article
Bawab et al. BMC Health Services Research          (2021) 21:216 
https://doi.org/10.1186/s12913-021-06217-6
Background
Diabetes is one of the most important chronic diseases
and contributes to mortality, morbidity and socio-
economic impacts [1]. Worldwide, it affects 9.3% of the
population, equal to approximately 463 million people
[2]. According to the International Diabetes Federation,
the number of people with diabetes will continue to in-
crease over the next decades [3]. To support these
people in the daily management of their treatments,
pharmacies can offer professional pharmacy services tai-
lored to the needs and interests of patients. The
provision of medicines to patients is not sufficient on its
own to achieve treatment goals, professional pharmacy
services are needed to enable pharmacists to address
medication-related needs [4].
Moullin et al. defined a professional pharmacy service
as “an action or set of actions undertaken in or orga-
nised by a pharmacy, delivered by a pharmacist or other
health practitioner, who applies their specialised health
knowledge personally or via an intermediary, with a pa-
tient or client, population or other health professional,
to optimise the process of care, with the aim to improve
health outcomes and the value of healthcare” [5].
To our knowledge, little data are available on interest in
pharmacy services among people with diabetes. If people
with diabetes have no interest in services offered by pharma-
cies, these will not been used and there would be no benefit
to public health. This study aimed to assess interest in and
use of pharmacy services among people with diabetes in-
cluded in the Cohort of Patients with Diabetes in the Canton
of Vaud (CoDiab-VD cohort) who responded to the 2017
annual questionnaire, which included a thematic module
about pharmacy services [6].
Methods
Study design
Data from a cross-sectional survey conducted in the fall
of 2017 as part of the CoDiad-VD cohort were used [6].
STROBE (Strengthening the Reporting of Observational
Studies in Epidemiology) guidelines were used in the
project’s execution and in the manuscript’s preparation
[7]. This study is registered with ClinicalTrials.gov, iden-
tifier NCT01902043.
Setting and participants
In Switzerland, community pharmacies can provide
pharmacy services, some of which are remunerated and
covered for patients by basic health insurance according
to the tariff headings [8]. These pharmacy services in-
clude pharmacists’ basic cognitive services (e.g., medica-
tion delivery, counselling services, prescription/dosage/
drug-drug interaction checks, and checks of patient re-
cords), medication intake support (directly observed
therapy, fractioned delivery or provision of a pill box
filled with medication for one or more weeks), or indi-
vidual interview with the pharmacist [8]. In 2016, the
Swiss Federal Council was invited to explore the various
possibilities for repositioning pharmacists in primary
care. The council stated that community pharmacists
have an important role to play and that shifting from
traditional medication delivery and counselling towards
the provision of patient-centred and interprofessional
pharmacy services was essential [9].
In 2011–12 and 2017, people with diabetes were re-
cruited into the CoDiab-VD cohort. Participation in the
CoDiab-VD cohort was offered to individuals visiting a
participating pharmacy with a diabetes-related prescrip-
tion. At the time of recruitment, non-institutionalised
adults (≥18 years old) who had been diagnosed with dia-
betes for at least 12 months and were living in the can-
ton of Vaud (French-speaking part of Switzerland) were
eligible. Women with gestational diabetes and individ-
uals with cognitive impairment or without sufficient
French language skills to complete the questionnaire
were excluded [6, 10]. In 2017, the questionnaire was
sent by mail to the participants recruited in 2011–12
and were distributed in-person in community pharma-
cies during the 2017 recruitment period.
Participants who were recruited in 2011–12 and 2017
were very similar at the time of recruitment in terms of
their sociodemographic characteristics, health status and
behaviours and self-reported diabetes status [11]. In
2017, the total number of respondents who answered to
the questionnaire was 790, including 276 individuals in-
cluded in the CoDiab-VD cohort who were recruited in
2011–12 and 514 newly recruited participants.
Study questionnaire and data collection
Participants completed a self-administered paper ques-
tionnaire that included questions on different aspects of
diabetes and diabetes care, questions on their own char-
acteristics, and a thematic module about pharmacy ser-
vices (see Additional File 1). The participants completed
the questionnaire at home and sent it back by mail to
the investigators. Participants were free to not answer
certain questions.
Measurements
For the purpose of this study, data collected on the par-
ticipants’ interest in and use of pharmacy services of-
fered by community pharmacies were used (very
interested, a little interested or not interested and already
used or never used). Two types of pharmacy services
were studied: (1) patient support in the management of
their medication intake and adherence (individual inter-
view with the pharmacist, SMS or email reminders for
medication intake, a smartphone application, (electronic)
pill boxes or weekly pill boxes, and treatment plans for
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all medications); (2) patient support in the management
of their diabetes and general health (screening for
chronic conditions, monitoring of blood levels or pres-
sure, influenza immunisation, counselling on the use of
devices, support to quit smoking or lose weight, first
medical opinions from pharmacists about health status,
and checks of all medications). Moreover, the partici-
pants’ interest in and use of consultation with their ref-
erence physicians were investigated.
We also used data collected on participants’ sociode-
mographic and economic characteristics, including age,
sex, education (primary - completion of compulsory
school or less, secondary - vocational training or high
school, or tertiary - university or technical college); fi-
nancial hardship affecting participants’ ability to pay
household bills during the last 12 months [12]; health
status, including perceived health status (first question
of the SF-12 questionnaire) [13] and body mass index
(kg/m2); health behaviours, including physical activity
(using questions from the Swiss Health Survey) [14],
smoking status and alcohol consumption (using the
AUDIT-C questionnaire) [15]; type of diabetes (type 1,
type 2, other or unknown); medication management, in-
cluding the frequency of pharmacy visits (≥1 time per
week, 2–3 times per month, 1 time per month, or < 1
time per month), the number of medications per day (1–
3, 4–6, 7–9, ≥10 medications) and the mode of adminis-
tration of antidiabetic medication (with or without insu-
lin or other injectable drugs); diabetes self-management,
including participation in diabetes education courses;
and self-efficacy according to the Stanford Diabetes Self-
efficacy scale [16]. Participants’ opinions (agree, disagree)
about their medications and pharmacists were also in-
vestigated. Participants’ opinions about their medications
were investigated with three questions (derived from the
Adherence Estimator, a three-item proximal screener for
the likelihood of non-adherence to prescription medica-
tions) [17]: 1. I am convinced of the importance of the
medications prescribed to me; 2. unreimbursed expenses
for medications prescribed to me are a financial burden;
3. I fear that the medications prescribed to me will do
me more harm than good. A composite variable for
opinion about medications was constructed: respondents
who answered respectively (strongly or somewhat) agree,
disagree, and disagree to the three above mentioned
questions were considered to have a positive opinion
about their medications. Participants’ opinions about
pharmacists were also investigated with three questions:
1. pharmacists are health professionals, just like physi-
cians and nurses; 2. pharmacists are experts in medica-
tions, side effects and medication interactions; 3.
pharmacists are just shopkeepers who sell products in
pharmacies. A composite variable for opinion about
pharmacists was constructed: respondents who answered
respectively (strongly or somewhat) agree, agree, and dis-
agree to the three above mentioned questions were con-
sidered to have a positive opinion about pharmacists.
The original questions in French and their English trans-
lations are available in the Additional File 1.
Statistical analyses
First, descriptive analyses were conducted to describe
participants’ characteristics, diabetes status (medications
and management), opinions about medications and
pharmacists, and interest in and use of both types of
pharmacy services. Then, multivariate logistic regression
analyses were performed to examine which factors were
associated with interest in both types of pharmacy ser-
vices, targeting items that interested at least 50% of the
respondents. The following covariates were considered
based on their a priori likelihood of influencing interest
in pharmacy services: age, sex, education, financial hard-
ship, antidiabetic medication including injections, par-
ticipation in diabetes education courses, Stanford
Diabetes Self-efficacy score, number of medications
taken per day (1–3, 4–6, and ≥ 7 medications per day,
with the latter category divided between 7 and 9 and ≥
10), positive opinion about medications, and positive
opinion about pharmacists. Odds ratios, predicted prob-
abilities and their 95% confidence intervals were esti-
mated. Moreover, the predicted probabilities of being
interested in pharmacy services were plotted according
to the number of medications taken per day and the age
of the participants, which are patient characteristics
known by pharmacists; sex was not present in the graph-
ics because of the absence of a difference in levels of
interest between females and males. All other covariates
in the logistic regression models were held constant.
Logistic regression models were assessed for influential
observations and tested their calibration using the
Hosmer-Lemeshow goodness-of-fit test. All statistical
analyses were performed using Stata 16.0 for Windows
(Stata Corporation, College Station, TX, USA, http://
www.stata.com). P-values < 0.05 were considered statisti-
cally significant.
Results
Table 1 details the sociodemographic characteristics,
health status and health behaviours of participants. The
mean age of the 790 participants was 66.0 years (range:
18 to 92 years), and the majority of participants were
men (59%). Among the participants, 53.2% reported hav-
ing a secondary education, and 32% reported having dif-
ficulty paying bills during the past 12 months. More
than the half of the participants (54%) were considered
physically active, and 80% were overweight or obese.
Most participants (72%) reported having type 2 dia-
betes, and more than half of participants (57%) received
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antidiabetic treatment including insulin or another in-
jectable. Most respondents (71%) took more than three
medications per day. Details of the frequency of phar-
macy visits, diabetes self-management, and participants’
opinions about medications and pharmacists are pre-
sented in Table 2.
The proportions of participants who were interested in
different pharmacy services and who declared having pre-
viously used them are presented in Fig. 1. Pharmacy ser-
vices that generated the greatest interest were also those
that were the most used: individual interview, pill boxes,
treatment plans, checks of all medications, first medical
opinions and counselling on devices. In addition, 85% of
the respondents were interested in receiving practical in-
formation about their medications during a medical con-
sultation with their physician, and 59% declared that they
already benefited from this service (data not illustrated).
The results of logistic regression analyses of the phar-
macy services that interested at least 50% of the partici-
pants are presented in Table 3; the predicted probabilities
are available in the Additional File 2.
Higher age, tertiary education, lower self-efficacy
score, taking more than three medications, and a posi-
tive opinion about pharmacists were all significantly as-
sociated with interest in certain pharmacy services. A
lower self-efficacy score was significantly associated with
greater interest in pill boxes, treatment plans, first med-
ical opinions, and counselling on device use. Taking
more than three medications was associated with greater
interest in individual interview with the pharmacist, pill
boxes, and treatment plans, while taking ≥7 medications
was associated with interest in checks of all medications.
Participants who reported a positive opinion about phar-
macists were more interested in individual interview
with the pharmacist, checks of all medications, first
medical opinions, and counselling on device use. Sex, fi-
nancial hardship, diabetes treatment including injections,
participation in diabetes education courses, and a posi-
tive opinion about medication were not significantly as-
sociated with interest in any of the pharmacy services
investigated.
Based on the logistic regression models, predicted
probabilities of being interested in pharmacy services
were computed according to number of medications
taken and age, with all other covariates held constant;
the results are presented in the Additional File 3. The
older participants were and the more medications they
took, the more they were interested in services related to
medication intake and adherence. For services related to
diabetes and general health, the trends were less clear; a
higher number of medications taken was associated with
higher probabilities of interest, while older age was asso-
ciated with lower probabilities of interest in those
services.
Table 1 Participants’ characteristics (sociodemographic
characteristics, health status and health behaviours)
Variable N totale % (N) or mean (SD)
Sociodemographic and economic characteristics












Perceived health statusb 779
Excellent 1.8% (14)





Underweight (< 15.5) 0.7% (5)
Normal (18.5–24.9) 19.7% (149)
Overweight (25–29.9) 38.0% (288)








Former smoker 42.2% (323)
Current smoker 18.8% (144)
Alcohol consumption 752
Not risky or not excessive 58.0% (462)
Risky or excessived 42.0% (313)
BMI Body mass index
a Difficulty paying bills in the last 12months
b First question of the Short Form Health Survey −12 (SF-12)
c Swiss Health Survey: active: ≥ 150 min of moderate physical activity or ≥ two
intense activities per week; partly active: 30 to 149 min of moderate physical
activity or one intense activity per week; inactive: < 30min of moderate
physical activity and < one intense activity per week
d Alcohol Use Disorders Identification Test-Consumption (AUDIT-C) score ≥ 4
for men and 3 for women
e The total number of respondents for each item varies since data were
collected through a self-administered paper questionnaire and participants
were free to not answer certain questions
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Table 2 Medication management, diabetes self-management, and participants’ opinions about their medications and pharmacists
Variable Total Ne %a (N) or mean (SD; min-max)
Medication management
Type of diabetes 790
Type 1 11.4% (90)
Type 2 72.0% (569)
Other or unknown 16.6% (131)
Frequency of pharmacy visits 747
≥ 1 time per week 6.7% (50)
2–3 times per month 30.1% (225)
1 time per month 35.3% (264)
< 1 time per month 27.8% (208)
Number of medications per day 773
1–3 medications 29.4% (227)
4–6 medications 41.9% (324)
7–9 medications 19.7% (152)
≥ 10 medications 9.1% (70)
Antidiabetic medication 788
Excluding insulin or other injectables 43.0% (339)
Including insulin or other injectables 57.0% (445)
Diabetes self-management
Participation in one or more diabetes education courses 771
Yes 35.4% (273)
No 64.6% (498)
Stanford Diabetes Self-efficacy overall scoreb 755 7.5 (1.8; 2.1–10.0)
Participants’ opinions about their medications
“Medications that are prescribed to me are important” 768
Disagree 4.2% (32)
Agree 95.8% (736)
“I fear that prescribed medication are more harmful than beneficial” 757
Disagree 86.4% (654)
Agree 13.6% (103)
“Non-reimbursed medications are burdensome for me” 760
Disagree 27.9% (212)
Agree 72.1% (548)
Positive opinion about medications on all 3 itemsc 770
Yes 23.6% (182)
No 76.4% (588)
Participants’ opinions about pharmacists
“Pharmacists are experts in medications, side effects and medication interactions” 741
Disagree 6.3% (47)
Agree 93.7% (694)
“Pharmacists are health professionals, just like physicians or nurses” 734
Disagree 15.7% (115)
Agree 84.3% (619)
“Pharmacists are just shopkeepers who sell products in pharmacy” 722
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Discussion
This study describes interest in and use of pharmacy ser-
vices among Swiss patients with diabetes in the CoDiab-
VD cohort. The pharmacy services that interested the
most respondents were individual interview, pill boxes,
treatment plans, checks of all medications, first medical
opinions from pharmacists and counselling on devices.
According to the participants, the most valuable phar-
macy services related to medication intake and adher-
ence as well as diabetes and general health were mainly
personal and patient-specific, which highlights the need
to individualise and target specific services based on pa-
tients’ personal needs. Furthermore, first medical opin-
ions and checks of all medications were the two services
with the greatest differences between interest and use
levels, indicating an opportunity to develop these ser-
vices to meet patients’ needs.
Factors positively associated with interest in pharmacy
services were higher age, higher education level, taking
four or more medications and a positive opinion about
pharmacists, while the self-efficacy score was negatively
associated with interest in pharmacy services. Partici-
pants’ opinions about their medications mainly showed
that their prescribed medications are important to them
and that they do not fear of harm from the medications
for 96 and 86% of respondents, respectively. Nearly three
quarters of respondents were rather concerned about
the non-reimbursement of medications. This finding
Table 2 Medication management, diabetes self-management, and participants’ opinions about their medications and pharmacists
(Continued)
Variable Total Ne %a (N) or mean (SD; min-max)
Disagree 85.9% (620)
Agree 14.1% (102)
Positive opinion about pharmacists on all 3 itemsd 764
Yes 65.5% (500)
No 34.6% (264)
a Due to rounding, the sum of the percentages is not always equal to 100%
b The Stanford Diabetes Self-efficacy overall score ranges from 0 to 10, with a higher score indicating a higher level of self-efficacy
c Composite variable for opinion about medication: respondents answering agree, disagree, and disagree to the three items, in that order, were considered to have
a positive opinion
d Composite variable for opinion about pharmacists: respondents answering agree, agree, and disagree to the three items, in that order, were considered to have a
positive opinion
e The total number of respondents for each item varies since data were collected through a self-administered paper questionnaire and participants were free to
not answer certain questions
Fig. 1 Pharmacy services interest and utilisation: medication intake and adherence (top), diabetes and general health (bottom)
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probably reflects a general concern about medications,
their prices and their reimbursement rather than a spe-
cific concern related to antidiabetic medications, as these
medications are all reimbursed in the Swiss health
system; the finding also shows the need to propose phar-
macy services that are reimbursed. In addition, medica-
tions can be dispensed to patients by pharmacies for up
to three months to be reimbursed by health insurances,
requiring frequent visits to the pharmacy. This gives
pharmacists the opportunity to play a key role in provid-
ing pharmaceutical support to the patient at each phar-
macy visit.
Pharmacists are very accessible health care profes-
sionals, as most of the respondents visited a pharmacy at
least once a month. This accessibility combined with the
positive opinion about pharmacists suggests that phar-
macists could actively participate in quality improvement
initiatives targeting the care of patients with chronic
conditions.
Multivariate analyses showed that the most notable
factors related to interest in pharmacy services were be-
ing older, having a lower self-efficacy score, taking more
than three medications and having a positive opinion
about pharmacists. Lower Stanford self-efficacy scores
mean that participants are less confident about being
able to overcome barriers and accomplish tasks. Lower
self-efficacy scores in this study were related to higher
interest in pharmacy services, which may have been re-
lated to patients’ beliefs about the need for pharmacy
services. When patients perceive the need for and bene-
fits of pharmacy services, they are more interested in
them [18]. In contrast, patients who believe they do not
need pharmacy services [19–21] and who are satisfied
with their current medication [19] logically have a lower
interest in, or use of, pharmacy services. Taking more
than three medications per day was associated with
greater interest in certain pharmacy services, confirming
that taking more medications is associated with a greater
number of drug-related problems, which is a measure of
the potential value of (interest in and use of) pharmacy
services from patients’ points of view [22, 23]. Moreover,
having a positive opinion about pharmacists can indicate
an appreciated personal relation with the pharmacist
based on good communication [21]. Seeing the pharma-
cist as a trusted and accessible expert in his or her area
of expertise is also associated with increased interest in
the use of pharmacy services [20]. In Switzerland, this
association has been identified by the national govern-
ment, which financially supports the scientific evaluation
of the implementation of an interprofessional and tai-
lored support programme (safety and medication adher-
ence) for people with type 2 diabetes [9, 24].
The main strength of this study was that the survey in-
cluded people with diabetes spread throughout a Swiss
region who were recruited from community pharmacies.
This approach should have allowed the inclusion of par-
ticipants who were more representative of the popula-
tion of patients with diabetes than if the recruitment had
been carried out in a specialised medical or hospital
setting.
In the interpretation of the results, the following limi-
tations need to be considered. Data were based exclu-
sively on self-reports, which involves the probable over-
or under-representation of certain phenomena. Without
access to other data, however, the use of this type of data
is considered appropriate [25]. The recruitment method
allowed us to limit selection bias; the limited selection
bias was also supported by the fact that the characteris-
tics of the participants in this cohort were comparable to
those of people with diabetes in other Swiss studies in
terms of age, sex, smoking status, body mass index, and
total number of medications taken [26–29].
Conclusion
The results of this study provide a better understanding
of the people who are most interested in pharmacy ser-
vices to support the assessment of their needs and the
development of tailored, appropriate solutions. These re-
sults should also motivate pharmacists to explain the im-
portance of pharmacy services so that people can
perceive their benefits. Since pharmacies are often vis-
ited by patients with chronic conditions, more effort
should be made to involve pharmacists in health promo-
tion or prevention initiatives such as flu vaccination and
weight loss or smoking cessation programmes.
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